Melanoma Clinical Trial
Registry Study for Talimogene Laherparepvec
Summary
A Registry Study to Evaluate the Survival and Long-Term Safety of Subjects Who Previously Received Talimogene Laherparepvec in Amgen or BioVEX-Sponsored Clinical Trials
Full Description
A registry study is to evaluate the overall survival, use of subsequent anti-cancer therapy, and the long-term safety of subjects who have received at least one dose of talimogene laherparepvec on an Amgen or BioVEX-sponsored clinical trial for any tumor type. Follow-Up will occur every 3 months.
Eligibility Criteria
Inclusion Criteria:
All subjects must provide informed consent prior to initiation of any study activities.
All subjects must have received at least one dose of talimogene laherparepvec on an Amgen or BioVEX-sponsored clinical trial for any tumor type and must have discontinued treatment and participation, including long-term follow-up (if applicable) in that trial.
Exclusion Criteria:
Subjects currently receiving talimogene laherparepvec in Amgen or BioVEX-sponsored clinical trial.
Subject currently participating, including for long-term follow-up (if applicable), in other Amgen-sponsored talimogene laherparepvec clinical trial.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 59 Locations for this study
Mobile Alabama, 36604, United States
Little Rock Arkansas, 72205, United States
Santa Rosa California, 95403, United States
Aurora Colorado, 80045, United States
Daytona Beach Florida, 32117, United States
Jacksonville Florida, 32207, United States
Miami Beach Florida, 33140, United States
Tampa Florida, 33612, United States
Park Ridge Illinois, 60068, United States
Indianapolis Indiana, 46260, United States
Minneapolis Minnesota, 55407, United States
Saint Louis Missouri, 63110, United States
Morristown New Jersey, 07962, United States
New Brunswick New Jersey, 08903, United States
Chapel Hill North Carolina, 27599, United States
Winston-Salem North Carolina, 27157, United States
Canton Ohio, 44718, United States
Portland Oregon, 97213, United States
Greenville South Carolina, 29605, United States
Germantown Tennessee, 38138, United States
Nashville Tennessee, 37232, United States
Dallas Texas, 75230, United States
Houston Texas, 77030, United States
Murray Utah, 84107, United States
Salt Lake City Utah, 84112, United States
Franklin Wisconsin, 53132, United States
Salzburg , 5020, Austria
Wien , 1090, Austria
Calgary Alberta, T2N 4, Canada
Edmonton Alberta, T6G 1, Canada
Toronto Ontario, M5G 2, Canada
Boulogne Billancourt , 92100, France
Nantes Cedex 1 , 44093, France
Heidelberg , 69120, Germany
Tübingen , 72076, Germany
Athens , 11527, Greece
Athens , 18547, Greece
Thessaloniki , 54622, Greece
Pecs , 7632, Hungary
Szeged , 6720, Hungary
Bergamo , 24127, Italy
Milano , 20141, Italy
Siena , 53100, Italy
Seoul , 03722, Korea, Republic of
Warszawa , 02-78, Poland
Moscow , 11547, Russian Federation
Saint-Petersburg , 19775, Russian Federation
Pretoria , 0081, South Africa
Barcelona Cataluña, 08036, Spain
Valencia Comunidad Valenciana, 46014, Spain
San Sebastian PaÃs Vasco, 20014, Spain
Madrid , 28041, Spain
Chur , 7000, Switzerland
Geneve , 1205, Switzerland
Lausanne , 1011, Switzerland
Zuerich Flughafen , 8058, Switzerland
London , SE1 9, United Kingdom
London , SW3 6, United Kingdom
Wirral , CH63 , United Kingdom
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.